Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 30 Apr 2026 | 31 Oct 2025 | 31 Jul 2025 | 30 Apr 2025 | 31 Oct 2024 | 31 Jul 2024 |
|---|---|---|---|---|---|---|
| Revenue | 11.13B | 10.26B | 10.24B | 9.83B | 9.44B | 9.33B |
| Cost of revenue | 2.57B | 2.26B | 2.24B | 2.27B | 2.11B | 2.16B |
| Gross profit | 8.56B | 8.00B | 7.99B | 7.56B | 7.34B | 7.17B |
| Research and development | 1.63B | 1.43B | 1.48B | 1.46B | 1.36B | 1.35B |
| Selling, general and administrative | 740M | 667M | 734M | 697M | 711M | 711M |
| Operating expenses | 6.22B | 5.82B | 5.66B | 5.62B | 5.45B | 5.38B |
| Operating income | 2.35B | 2.19B | 2.33B | 1.94B | 1.89B | 1.78B |
| Pre-tax income | 2.72B | 2.51B | 2.41B | 1.97B | 1.75B | 1.84B |
| Income tax | 614M | 426M | 519M | 433M | 219M | 408M |
| Net income | 2.11B | 2.09B | 1.89B | 1.54B | 1.53B | 1.43B |
| Earnings per share | 2.43 | 2.20 | 1.97 | 1.61 | 1.60 | 1.48 |
| Earnings per share, diluted | 2.42 | 2.19 | 1.96 | 1.59 | 1.58 | 1.47 |
| Weighted average shares | 868M | 948M | 956M | 960M | 956M | 964M |
| Weighted average shares, diluted | 871M | 952M | 962M | 970M | 965M | 973M |
| Metric | 30 Apr 2026 | 31 Jan 2026 | 31 Oct 2025 | 31 Jul 2025 | 30 Apr 2025 | 31 Jan 2025 | 31 Oct 2024 | 31 Jul 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 8.94B | 7.33B | 8.98B | 10.37B | 10.93B | 8.85B | 8.00B | 7.68B |
| Receivables | 5.08B | 14.34B | 5.47B |
| Metric | 30 Apr 2026 | 31 Oct 2025 | 31 Jul 2025 | 30 Apr 2025 | 31 Oct 2024 | 31 Jul 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | 6.70B | 2.32B | 740M | 6.48B | 1.98B | 892M |
| Depreciation and amortisation | 985M | 851M | 817M | 843M | 814M | 907M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 5.60B |
| 4.35B |
| 11.95B |
| 4.74B |
| 5.39B |
| Current assets | 21.61B | 28.22B | 21.06B | 25.33B | 25.87B | 29.73B | 21.43B | 21.86B |
| Goodwill | 59.29B | 57.94B | 52.46B | 51.44B | 51.28B | 51.28B | 49.09B | 48.94B |
| Total assets | 106.68B | 112.31B | 95.14B | 97.57B | 98.61B | 102.93B | 91.40B | 92.18B |
| Current liabilities | 27.50B | 37.12B | 21.41B | 22.53B | 24.20B | 27.98B | 19.38B | 21.00B |
| Long-term debt | 39.28B | 10.44B | 8.44B | 8.44B | 8.44B | 8.43B | 8.43B | 8.43B |
| Total liabilities | 72.45B | 53.16B | 35.12B | 36.25B | 37.94B | 41.76B | 32.87B | 34.55B |
| Equity | 34.24B | 59.14B | 60.02B | 61.33B | 60.67B | 61.17B | 58.53B | 57.63B |
| Shares outstanding | — | 929M | — | — | — | 962M | — | — |
| Shares issued | — | 1.07B | — | — | — | 1.06B | — | — |
| Share-based compensation | 857M | 819M | 793M | 814M | 820M | 810M |
| Capital expenditure | 145M | 139M | 135M | 179M | 204M | 137M |
| Investing cash flow | −2.18B | 519M | 1.17B | −1.57B | −217M | 2.64B |
| Dividends paid | 365M | 395M | 399M | 402M | 382M | 384M |
| Share buybacks | 27.25B | 3.80B | 2.23B | 2.63B | 1.29B | 4.34B |
| Financing cash flow | −2.92B | −4.24B | −2.50B | −2.92B | −1.45B | −5.80B |